truqap - capivasertib tablet, film coated
(Capivasertib)Astrazeneca Pharmaceuticals Lp
Usage: Truqap is a kinase inhibitor used with fulvestrant to treat adults with HR-positive, HER2-negative locally advanced or metastatic breast cancer with PIK3CA/AKT1/PTEN alterations, and with abiraterone and prednisone to treat adults with PTEN-deficient metastatic prostate cancer.